However, in colorectal cancer, NRF2 has a dual role: it protects cells from carcinogenic damage in the early stages and increases tumor aggressiveness and resistance to chemotherapy in the later stages (O'Cathail et al., 2021; Pompili et al., 2019; Taheri et al., 2020). Here, NFE2L2 is linked to neoplasm.